HEADER TRANSCRIPTION/INHIBITOR 13-MAR-19 6O98 TITLE CRYSTAL STRUCTURE OF RAR-RELATED ORPHAN RECEPTOR C IN COMPLEX WITH A TITLE 2 PHENYL (3-PHENYLPYRROLIDIN-3-YL)SULFONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN (UNP RESIDUES 265-508); COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 6 GROUP F MEMBER 3, RAR-RELATED ORPHAN RECEPTOR C, RETINOID-RELATED COMPND 7 ORPHAN RECEPTOR-GAMMA; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RORGT, NUCLEAR HORMONE RECEPTOR, LIGAND-BINDING DOMAIN, INVERSE KEYWDS 2 AGONIST, TRANSCRIPTION-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SACK REVDAT 3 11-OCT-23 6O98 1 REMARK REVDAT 2 03-APR-19 6O98 1 JRNL REVDAT 1 20-MAR-19 6O98 0 SPRSDE 20-MAR-19 6O98 6NXH JRNL AUTH J.J.DUAN,Z.LU,B.JIANG,S.STACHURA,C.A.WEIGELT,J.S.SACK, JRNL AUTH 2 J.KHAN,M.RUZANOV,M.A.GALELLA,D.R.WU,M.YARDE,D.R.SHEN, JRNL AUTH 3 D.J.SHUSTER,V.BOROWSKI,J.H.XIE,L.ZHANG,S.VANTERU,A.K.GUPTA, JRNL AUTH 4 A.MATHUR,Q.ZHAO,W.FOSTER,L.M.SALTER-CID,P.H.CARTER, JRNL AUTH 5 T.G.M.DHAR JRNL TITL STRUCTURE-BASED DISCOVERY OF PHENYL JRNL TITL 2 (3-PHENYLPYRROLIDIN-3-YL)SULFONES AS SELECTIVE, ORALLY JRNL TITL 3 ACTIVE ROR GAMMA T INVERSE AGONISTS. JRNL REF ACS MED CHEM LETT V. 10 367 2019 JRNL REFN ISSN 1948-5875 JRNL PMID 30891142 JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00010 REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 70.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.5 REMARK 3 NUMBER OF REFLECTIONS : 27743 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.248 REMARK 3 R VALUE (WORKING SET) : 0.246 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1393 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.35 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 21.36 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 555 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1828 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 531 REMARK 3 BIN R VALUE (WORKING SET) : 0.1817 REMARK 3 BIN FREE R VALUE : 0.2078 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.32 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3616 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 5 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 71.57 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 67.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.58810 REMARK 3 B22 (A**2) : 0.58810 REMARK 3 B33 (A**2) : -1.17620 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.490 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.291 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.229 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.311 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.238 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.896 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.874 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3776 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5104 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1382 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 670 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3776 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 464 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4472 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.06 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.76 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6O98 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAR-19. REMARK 100 THE DEPOSITION ID IS D_1000240251. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAR-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27744 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.290 REMARK 200 RESOLUTION RANGE LOW (A) : 84.690 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 9.900 REMARK 200 R MERGE (I) : 0.17600 REMARK 200 R SYM (I) : 0.17600 REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.29 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 58.7 REMARK 200 DATA REDUNDANCY IN SHELL : 9.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 6BN6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: UNSPECIFIED, VAPOR DIFFUSION, HANGING REMARK 280 DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.09333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 84.18667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 63.14000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 105.23333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 21.04667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 223 REMARK 465 GLY A 224 REMARK 465 SER A 225 REMARK 465 SER A 226 REMARK 465 HIS A 227 REMARK 465 HIS A 228 REMARK 465 HIS A 229 REMARK 465 HIS A 230 REMARK 465 HIS A 231 REMARK 465 HIS A 232 REMARK 465 SER A 233 REMARK 465 SER A 234 REMARK 465 GLY A 235 REMARK 465 LEU A 236 REMARK 465 VAL A 237 REMARK 465 PRO A 238 REMARK 465 ARG A 239 REMARK 465 GLY A 240 REMARK 465 SER A 241 REMARK 465 HIS A 242 REMARK 465 MET A 243 REMARK 465 HIS A 467 REMARK 465 LEU A 468 REMARK 465 HIS A 469 REMARK 465 PRO A 470 REMARK 465 ILE A 471 REMARK 465 VAL A 472 REMARK 465 VAL A 473 REMARK 465 GLN A 474 REMARK 465 ALA A 475 REMARK 465 ALA A 476 REMARK 465 PHE A 477 REMARK 465 PRO A 478 REMARK 465 PRO A 479 REMARK 465 LEU A 480 REMARK 465 TYR A 481 REMARK 465 LYS A 482 REMARK 465 GLU A 483 REMARK 465 LEU A 484 REMARK 465 PHE A 485 REMARK 465 SER A 486 REMARK 465 THR A 487 REMARK 465 MET B 223 REMARK 465 GLY B 224 REMARK 465 SER B 225 REMARK 465 SER B 226 REMARK 465 HIS B 227 REMARK 465 HIS B 228 REMARK 465 HIS B 229 REMARK 465 HIS B 230 REMARK 465 HIS B 231 REMARK 465 HIS B 232 REMARK 465 SER B 233 REMARK 465 SER B 234 REMARK 465 GLY B 235 REMARK 465 LEU B 236 REMARK 465 VAL B 237 REMARK 465 PRO B 238 REMARK 465 ARG B 239 REMARK 465 GLY B 240 REMARK 465 SER B 241 REMARK 465 HIS B 242 REMARK 465 GLN B 466 REMARK 465 HIS B 467 REMARK 465 LEU B 468 REMARK 465 HIS B 469 REMARK 465 PRO B 470 REMARK 465 ILE B 471 REMARK 465 VAL B 472 REMARK 465 VAL B 473 REMARK 465 GLN B 474 REMARK 465 ALA B 475 REMARK 465 ALA B 476 REMARK 465 PHE B 477 REMARK 465 PRO B 478 REMARK 465 PRO B 479 REMARK 465 LEU B 480 REMARK 465 TYR B 481 REMARK 465 LYS B 482 REMARK 465 GLU B 483 REMARK 465 LEU B 484 REMARK 465 PHE B 485 REMARK 465 SER B 486 REMARK 465 THR B 487 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 457 CG CD OE1 NE2 REMARK 470 MET B 243 CG SD CE REMARK 470 LYS B 448 CG CD CE NZ REMARK 470 LYS B 450 CG CD CE NZ REMARK 470 ARG B 452 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 461 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 265 -68.08 73.33 REMARK 500 GLN B 265 -63.98 73.23 REMARK 500 LYS B 448 105.01 -34.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L8A A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue L8A B 601 DBREF 6O98 A 244 487 UNP P51449 RORG_HUMAN 265 508 DBREF 6O98 B 244 487 UNP P51449 RORG_HUMAN 265 508 SEQADV 6O98 MET A 223 UNP P51449 EXPRESSION TAG SEQADV 6O98 GLY A 224 UNP P51449 EXPRESSION TAG SEQADV 6O98 SER A 225 UNP P51449 EXPRESSION TAG SEQADV 6O98 SER A 226 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS A 227 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS A 228 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS A 229 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS A 230 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS A 231 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS A 232 UNP P51449 EXPRESSION TAG SEQADV 6O98 SER A 233 UNP P51449 EXPRESSION TAG SEQADV 6O98 SER A 234 UNP P51449 EXPRESSION TAG SEQADV 6O98 GLY A 235 UNP P51449 EXPRESSION TAG SEQADV 6O98 LEU A 236 UNP P51449 EXPRESSION TAG SEQADV 6O98 VAL A 237 UNP P51449 EXPRESSION TAG SEQADV 6O98 PRO A 238 UNP P51449 EXPRESSION TAG SEQADV 6O98 ARG A 239 UNP P51449 EXPRESSION TAG SEQADV 6O98 GLY A 240 UNP P51449 EXPRESSION TAG SEQADV 6O98 SER A 241 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS A 242 UNP P51449 EXPRESSION TAG SEQADV 6O98 MET A 243 UNP P51449 EXPRESSION TAG SEQADV 6O98 MET B 223 UNP P51449 EXPRESSION TAG SEQADV 6O98 GLY B 224 UNP P51449 EXPRESSION TAG SEQADV 6O98 SER B 225 UNP P51449 EXPRESSION TAG SEQADV 6O98 SER B 226 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS B 227 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS B 228 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS B 229 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS B 230 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS B 231 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS B 232 UNP P51449 EXPRESSION TAG SEQADV 6O98 SER B 233 UNP P51449 EXPRESSION TAG SEQADV 6O98 SER B 234 UNP P51449 EXPRESSION TAG SEQADV 6O98 GLY B 235 UNP P51449 EXPRESSION TAG SEQADV 6O98 LEU B 236 UNP P51449 EXPRESSION TAG SEQADV 6O98 VAL B 237 UNP P51449 EXPRESSION TAG SEQADV 6O98 PRO B 238 UNP P51449 EXPRESSION TAG SEQADV 6O98 ARG B 239 UNP P51449 EXPRESSION TAG SEQADV 6O98 GLY B 240 UNP P51449 EXPRESSION TAG SEQADV 6O98 SER B 241 UNP P51449 EXPRESSION TAG SEQADV 6O98 HIS B 242 UNP P51449 EXPRESSION TAG SEQADV 6O98 MET B 243 UNP P51449 EXPRESSION TAG SEQRES 1 A 265 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 265 LEU VAL PRO ARG GLY SER HIS MET ALA SER LEU THR GLU SEQRES 3 A 265 ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR ARG SEQRES 4 A 265 GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN SEQRES 5 A 265 ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR SEQRES 6 A 265 GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA SEQRES 7 A 265 HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE SEQRES 8 A 265 ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN ASN SEQRES 9 A 265 ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL SEQRES 10 A 265 VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN SEQRES 11 A 265 ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU SEQRES 12 A 265 LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER SEQRES 13 A 265 ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SEQRES 14 A 265 SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU SEQRES 15 A 265 ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS SEQRES 16 A 265 VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS SEQRES 17 A 265 HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA SEQRES 18 A 265 LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER SEQRES 19 A 265 GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS SEQRES 20 A 265 PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS SEQRES 21 A 265 GLU LEU PHE SER THR SEQRES 1 B 265 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 265 LEU VAL PRO ARG GLY SER HIS MET ALA SER LEU THR GLU SEQRES 3 B 265 ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR ARG SEQRES 4 B 265 GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN SEQRES 5 B 265 ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR SEQRES 6 B 265 GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA SEQRES 7 B 265 HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE SEQRES 8 B 265 ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN ASN SEQRES 9 B 265 ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL SEQRES 10 B 265 VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN SEQRES 11 B 265 ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU SEQRES 12 B 265 LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER SEQRES 13 B 265 ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SEQRES 14 B 265 SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU SEQRES 15 B 265 ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS SEQRES 16 B 265 VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS SEQRES 17 B 265 HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA SEQRES 18 B 265 LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER SEQRES 19 B 265 GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS SEQRES 20 B 265 PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS SEQRES 21 B 265 GLU LEU PHE SER THR HET L8A A 601 42 HET L8A B 601 42 HETNAM L8A 1-(4-{(3R)-3-[(4-FLUOROPHENYL)SULFONYL]-3-[4-(1,1,1,3, HETNAM 2 L8A 3,3-HEXAFLUORO-2-HYDROXYPROPAN-2-YL) HETNAM 3 L8A PHENYL]PYRROLIDINE-1-CARBONYL}PIPERAZIN-1-YL)ETHAN-1- HETNAM 4 L8A ONE FORMUL 3 L8A 2(C26 H26 F7 N3 O5 S) FORMUL 5 HOH *5(H2 O) HELIX 1 AA1 SER A 245 THR A 263 1 19 HELIX 2 AA2 ARG A 267 GLN A 274 1 8 HELIX 3 AA3 ARG A 275 ASN A 277 5 3 HELIX 4 AA4 SER A 280 LYS A 290 1 11 HELIX 5 AA5 SER A 291 ARG A 316 1 26 HELIX 6 AA6 LEU A 317 LEU A 323 1 7 HELIX 7 AA7 CYS A 324 MET A 344 1 21 HELIX 8 AA8 GLY A 363 GLY A 371 5 9 HELIX 9 AA9 CYS A 372 ALA A 388 1 17 HELIX 10 AB1 SER A 392 ILE A 405 1 14 HELIX 11 AB2 GLU A 414 THR A 436 1 23 HELIX 12 AB3 ARG A 438 LEU A 442 5 5 HELIX 13 AB4 GLY A 449 GLN A 463 1 15 HELIX 14 AB5 SER B 245 THR B 263 1 19 HELIX 15 AB6 ARG B 267 GLN B 274 1 8 HELIX 16 AB7 ARG B 275 ASN B 277 5 3 HELIX 17 AB8 SER B 280 LYS B 290 1 11 HELIX 18 AB9 SER B 291 ARG B 316 1 26 HELIX 19 AC1 LEU B 317 LEU B 323 1 7 HELIX 20 AC2 CYS B 324 MET B 344 1 21 HELIX 21 AC3 GLY B 363 GLY B 371 5 9 HELIX 22 AC4 CYS B 372 ALA B 388 1 17 HELIX 23 AC5 SER B 392 ILE B 405 1 14 HELIX 24 AC6 GLU B 414 THR B 436 1 23 HELIX 25 AC7 ARG B 438 LEU B 442 5 5 HELIX 26 AC8 GLY B 449 PHE B 465 1 17 SHEET 1 AA1 3 TYR A 348 ASN A 349 0 SHEET 2 AA1 3 THR A 354 PHE A 357 -1 O THR A 354 N ASN A 349 SHEET 3 AA1 3 LYS A 360 GLY A 362 -1 O LYS A 360 N PHE A 357 SHEET 1 AA2 3 TYR B 348 ASN B 349 0 SHEET 2 AA2 3 THR B 354 PHE B 357 -1 O THR B 354 N ASN B 349 SHEET 3 AA2 3 LYS B 360 GLY B 362 -1 O LYS B 360 N PHE B 357 SITE 1 AC1 19 CYS A 264 GLN A 265 LEU A 271 TRP A 296 SITE 2 AC1 19 CYS A 299 HIS A 302 LEU A 303 MET A 337 SITE 3 AC1 19 MET A 344 ARG A 346 ALA A 347 VAL A 355 SITE 4 AC1 19 PHE A 357 PHE A 367 ILE A 376 ILE A 379 SITE 5 AC1 19 PHE A 380 HIS A 458 LEU A 462 SITE 1 AC2 16 CYS B 264 LEU B 271 TRP B 296 CYS B 299 SITE 2 AC2 16 HIS B 302 LEU B 303 MET B 337 MET B 344 SITE 3 AC2 16 ARG B 346 ALA B 347 PHE B 357 PHE B 367 SITE 4 AC2 16 ILE B 376 ILE B 379 HIS B 458 LEU B 462 CRYST1 97.780 97.780 126.280 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010227 0.005905 0.000000 0.00000 SCALE2 0.000000 0.011809 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007919 0.00000